Literature DB >> 25536262

Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.

Chang-Fu Kuo1, Matthew J Grainge2, Christian Mallen3, Weiya Zhang4, Michael Doherty4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25536262     DOI： 10.1001/jama.2014.14484

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  24 in total

Review 1.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 2.  Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?

Authors:  Zahira Latif; Abhishek Abhishek
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

Review 3.  [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].

Authors:  L Sellin; J T Kielstein; K de Groot
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

4.  Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies.

Authors:  Sharan K Rai; Hyon K Choi; Sally H J Choi; Anne F Townsend; Kam Shojania; Mary A De Vera
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

5.  Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016.

Authors:  Michael Chen-Xu; Chio Yokose; Sharan K Rai; Michael H Pillinger; Hyon K Choi
Journal:  Arthritis Rheumatol       Date:  2019-04-15       Impact factor: 10.995

6.  Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011.

Authors:  Sharan K Rai; J Antonio Aviña-Zubieta; Natalie McCormick; Mary A De Vera; Diane Lacaille; Eric C Sayre; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05       Impact factor: 4.794

Review 7.  [Hyperuricemia. When and how to treat?].

Authors:  M A Reuss-Borst
Journal:  Internist (Berl)       Date:  2016-02       Impact factor: 0.743

8.  Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.

Authors:  Ana Beatriz Vargas-Santos; Christine E Peloquin; Yuqing Zhang; Tuhina Neogi
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

9.  Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.

Authors:  Na Lu; Sharan K Rai; Robert Terkeltaub; Seoyoung C Kim; Mariano E Menendez; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-03-31       Impact factor: 5.532

10.  Factors Influencing Allopurinol Initiation in Primary Care.

Authors:  Lorna E Clarson; Samantha L Hider; John Belcher; Edward Roddy; Christian D Mallen
Journal:  Ann Fam Med       Date:  2017-11       Impact factor: 5.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.